α-L-Fucosidase: A potential biomarker for differential diagnosis of autoimmune hepatitis and drug-induced autoimmune hepatitis - 22/12/24
Doi : 10.1016/j.clinre.2024.102517
Yingying Lin a, 1, Xinyu Cui b, 1, Yanyan Li b, Na Zhu b, Xin Li a, ⁎ 
a Department of Center of Integrated Traditional Chinese and Western Medicine, Peking University Ditan Teaching Hospital, Beijing, China
b Department of Center of Integrated Traditional Chinese and Western Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, China
⁎Corresponding author at: Department of Center of Integrated Traditional Chinese and Western Medicine, Peking University Ditan Teaching Hospital, No. 8, Jingshun East Street, Chaoyang District, Beijing, 100015, China.Department of Center of Integrated Traditional Chinese and Western MedicinePeking University Ditan Teaching HospitalNo. 8, Jingshun East Street, Chaoyang DistrictBeijing100015China
Highlights |
• | The extremely similar clinical features of AIH and DI-AIH make differentiating difficult. |
• | No method can effectively identify AIH and DI-AIH. |
• | α-l-fucosidase exhibits differential expression and diagnostic value between AIH and DI-AIH. |
• | The results of this study may inspire more relevant studies in the future. |
Keywords : Autoimmune hepatitis, Drug-induced autoimmune hepatitis, α-l-fucosidase, Diagnosis
Plan
© 2024
Publié par Elsevier Masson SAS.
Vol 49 - N° 1
Article 102517- janvier 2025 Retour au numéro
Article précédent
- "Shared genes, different clinical challenges: A new likely pathogenic variant in the ABCB4 gene"
- Sandra Ribeiro Correia, Tiago Pereira Guedes, Jorge Diogo Da Silva, Nataliya Tkachenko, Isabel Pedroto
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?